The Patent Finder

Cell Signaling Technology, Inc.

Also on record
Records under this name other than the patents Cell Signaling Technology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 38 patents it holds.

Back to Cell Signaling Technology, Inc.

PatentTitleStatus Expires Confidence
US 10,208,125Anti-Mucin 1 Binding Agents and Uses Thereof
now held by University of Pittsburgh - of the Commonwealth System of Higher Education - of the Commonwealth System of Higher Education
In force
 · High confidence
In forceHigh confidence
US 11,428,696Mass Spectrometry Analysis of Mutant Polypeptides in Biological Samples
Lapsed on the fee record
Ended Aug 30, 2026 · High confidence
Lapsed on the fee recordEnded Aug 30, 2026High confidence
US 7,932,044Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing Pdgfr-Alpha
Term ended
Term ended Jul 1, 2025 · High confidence
Term endedTerm ended Jul 1, 2025High confidence
US 8,466,160Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHA
Term ended
Term ended Jul 1, 2025 · High confidence
Term endedTerm ended Jul 1, 2025High confidence
US 7,105,642Monoclonal Antibodies Specific for Phosphorylated Estrogen Receptor Alpha (SER118) and Uses Thereof
Term ended
Term ended May 28, 2024 · High confidence
Term endedTerm ended May 28, 2024High confidence
US 7,183,385Phospho-Specific Antibodies to FLT3 and Uses Thereof
Term ended
Term ended Apr 23, 2024 · High confidence
Term endedTerm ended Apr 23, 2024High confidence
US 8,512,967Method for Predicting the Response to HER2-DIRECTED Therapy
Term ended
Term ended Apr 7, 2023 · High confidence
Term endedTerm ended Apr 7, 2023High confidence
US 8,956,822Method for Predicting the Response to HER2-DIRECTED Therapy
Term ended
Term ended Apr 7, 2023 · High confidence
Term endedTerm ended Apr 7, 2023High confidence
US 9,239,331Method for Predicting the Response to HER2-DIRECTED Therapy
Term ended
Term ended Apr 7, 2023 · High confidence
Term endedTerm ended Apr 7, 2023High confidence
US 7,344,714Production of Motif-Specific and Context-Independent Antibodies Using Peptide Libraries as Antigens
Term ended
Ended no later than Dec 24, 2020 · Low confidence
Term endedEnded no later than Dec 24, 2020Low confidence
10 of 87 records shown.
Pro members see all 87.
Pro members: see all 87 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited